59 related articles for article (PubMed ID: 13424329)
1. Heparin monosulphuric acid, beta-heparin and dog mast cell tumour heparin in different clotting systems.
MAGNUSSON S; NILSSON IM
Acta Physiol Scand; 1957 Apr; 39(1):36-46. PubMed ID: 13424329
[No Abstract] [Full Text] [Related]
2. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
[TBL] [Abstract][Full Text] [Related]
4. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
Samoszuk M; Corwin M; Hazen SL
Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
[TBL] [Abstract][Full Text] [Related]
5. Chemorheological studies of the effect of heparin on the course of coagulation.
Overholser KA; Baysinger CB; Harris TR; Deveau T
Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
[TBL] [Abstract][Full Text] [Related]
7. The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system.
Gaszyński W
Anaesth Resusc Intensive Ther; 1975; 3(2):125-34. PubMed ID: 1080969
[TBL] [Abstract][Full Text] [Related]
8. The effect of suboptimal concentrations of sodium citrate upon the clotting times of human and dog blood after intravenous administration of heparin.
LOSNER S; VOLK BW
Am J Med Sci; 1952 Dec; 224(6):673-8. PubMed ID: 12996513
[No Abstract] [Full Text] [Related]
9. [Effect of intratracheal administration of heparin on the status of the mast cell population in the rat].
Orlova AG; Chernova OV; Rozkin MIa; Efimov VS
Farmakol Toksikol; 1989; 52(3):55-9. PubMed ID: 2792355
[TBL] [Abstract][Full Text] [Related]
10. A new route of heparin administration--the lung.
Kavanagh LW; Jaques LB
Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
Hellebrekers LJ; Slappendel RJ; van den Brom WE
Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
Harenberg J
J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
[TBL] [Abstract][Full Text] [Related]
13. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
Hunt BJ; Segal HC; Yacoub M
J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
[No Abstract] [Full Text] [Related]
15. Possible mechanism of the synergistic effect of heparin and dihydroergotamine.
Kakkar VV; Welzel D; Murray WJ; Malone P; Jones D
Am J Surg; 1985 Oct; 150(4A):33-8. PubMed ID: 4051120
[TBL] [Abstract][Full Text] [Related]
16. [Effect of low-molecular heparin on blood coagulation].
Harenberg J; de Vries JX; Weber E; Zimmermann R
Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
[TBL] [Abstract][Full Text] [Related]
18. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
19. Clotting factor assays on plasma from patients receiving intramuscular of subcutaneous heparin.
RAPAPORT SI; AMES SB
Am J Med Sci; 1957 Dec; 234(6):678-86. PubMed ID: 13487576
[No Abstract] [Full Text] [Related]
20. Venous activated clotting time after intra-arterial heparin: effect of site of administration and timing of sampling.
Kerensky RA; Azar GJ; Bertolet B; Hill JA; Kutcher MA
Cathet Cardiovasc Diagn; 1996 Feb; 37(2):151-3. PubMed ID: 8808070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
